| Foreword |
|
v | |
| Preface |
|
xiv | |
|
|
|
xxv | |
|
Intraarterial Contrast-Enhanced Ultrasonography Is the Final Goal of Intravenous Contrast-Enhanced Ultrasonography |
|
|
1 | (3) |
|
Types of Contrast-Enhanced Ultrasonography |
|
|
1 | (1) |
|
Intraarterial Contrast-Enhanced US |
|
|
1 | (2) |
|
|
|
1 | (1) |
|
Update of Intraarterial Contrast-Enhanced US |
|
|
2 | (1) |
|
Observation Tips for Intraarterial Contrast-Enhanced US |
|
|
2 | (1) |
|
Vascular Patterns on Intraarterial Contrast-Enhanced US |
|
|
2 | (1) |
|
Indications for Intraarterial Contrast-Enhanced US |
|
|
3 | (1) |
|
Intraarterial Contrast-Enhanced US Is the Final Goal of (or the Gold Standard for) Intravenous Contrast-Enhanced US |
|
|
3 | (1) |
|
Vascularity and Hemodynamics of Liver Tumors as Seen with Intraarterial Contrast-Enhanced Ultrasonography |
|
|
4 | (8) |
|
|
|
4 | (3) |
|
|
|
7 | (1) |
|
Dysplastic Nodule or Adenomatous Hyperplasia |
|
|
7 | (1) |
|
Well-differentiated HCC Containing a Moderately Differentiated Focus (Nodule in Nodule) |
|
|
8 | (1) |
|
Focal Nodular Hyperplasia |
|
|
9 | (1) |
|
|
|
9 | (3) |
|
Intranodular Hemodynamic Transition Associated with Dedifferentiation of Hepatocellular Carcinoma |
|
|
12 | (2) |
|
Hepatocellular Carcinoma and the Role of Blood Flow Imaging in Clinical Practice |
|
|
14 | (1) |
|
|
|
15 | (4) |
|
Overview of Levovist: A Diagnostic Ultrasonic Contrast Agent |
|
|
15 | (1) |
|
|
|
15 | (1) |
|
|
|
15 | (1) |
|
|
|
16 | (1) |
|
|
|
16 | (3) |
|
Comparative Pharmacokinetic Behavior of Levovist with Water-Soluble Contrast Agents |
|
|
19 | (3) |
|
Levovist Versus Water-Soluble Contrast Agents |
|
|
19 | (1) |
|
Pharmacokinetic Behavior of Levovist |
|
|
20 | (1) |
|
Time Phases of Levovist Contrast-Enhanced US |
|
|
20 | (2) |
|
Various Contrast-Enhanced Imaging Modes After Administration of Levovist |
|
|
22 | (4) |
|
Contrast-Enhanced Doppler Imaging |
|
|
22 | (1) |
|
|
|
22 | (1) |
|
Harmonic Power Doppler Imaging |
|
|
23 | (1) |
|
Harmonic Gray-Scale Imaging |
|
|
23 | (1) |
|
Digital Subtraction Harmonic B-Mode Imaging |
|
|
24 | (1) |
|
Phase (Pulse) Inversion Harmonics |
|
|
25 | (1) |
|
Coded Harmonic Angio Mode |
|
|
25 | (1) |
|
Glossary of Harmonic Imaging Terms |
|
|
26 | (3) |
|
Principles of Harmonic Imaging |
|
|
29 | (2) |
|
Harmonic Power Doppler and Other New Techniques on ALOKA ProSound Series |
|
|
31 | (38) |
|
Principles of Harmonic Power Doppler |
|
|
31 | (1) |
|
Principles and Features of ALOKA ProSound Series (SSD-5500 and SSD-6500) |
|
|
32 | (6) |
|
Principles of Extended Pure Harmonic Detection |
|
|
32 | (5) |
|
Features of ALOKA ProSound Series |
|
|
37 | (1) |
|
Application Method and Main Point for ALOKA ProSound SSD-5500 |
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
Application Method and Main Point for ALOKA Prosound SSD-6500 |
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (1) |
|
Clinical Cases of Using the Harmonic Power Flow Function on ALOKA ProSound SSD-5500 |
|
|
40 | (14) |
|
Hepatocellular carcinoma: Difference of the stain degree based on different intermittent intervals |
|
|
40 | (1) |
|
Harmonic Power Flow image of a giant hepatic tumor |
|
|
41 | (2) |
|
A case of hypervascular hepatocellular carcinoma (HCC) |
|
|
43 | (1) |
|
A case of hypovascular HCC |
|
|
44 | (1) |
|
HCC: Clear visualization of central necrosis by Harmonic Power Flow |
|
|
45 | (1) |
|
Harmonic Power Flow image of a deeply located HCC |
|
|
46 | (2) |
|
Harmonic Power Flow image of HCC recurrence and necrosis |
|
|
48 | (1) |
|
|
|
49 | (1) |
|
Focal nodular hyperplasia: Spoke-wheel pattern of blood supply and dense stain of the nodule |
|
|
50 | (2) |
|
Subtraction harmonic image of small HCC nodules |
|
|
52 | (1) |
|
Evaluation of treatment response after TAE combined with RFA |
|
|
53 | (1) |
|
Clinical Cases of Using CHE on ALOKA ProSound SSD-6500 |
|
|
54 | (13) |
|
Large HCC: Typical HCC findings shown by CHE mode |
|
|
54 | (1) |
|
|
|
55 | (2) |
|
CHE images of metastatic liver cancer |
|
|
57 | (1) |
|
HCC after transcatheter arterial infusion treatment |
|
|
58 | (2) |
|
Nodule-in-nodule type HCC: Clearly observed by CHE mode |
|
|
60 | (1) |
|
HCC post-RFA: Evaluation of treatment response |
|
|
61 | (2) |
|
|
|
63 | (1) |
|
Typical findings on CHE of HCC |
|
|
64 | (2) |
|
|
|
66 | (1) |
|
|
|
67 | (2) |
|
Contrast Imaging (Toshiba PowerVision 8000 and Aplio) |
|
|
69 | (52) |
|
Nonlinear Phenomenon of Microbubbles in an Ultrasonic Contrast Agent |
|
|
69 | (1) |
|
Contrast Imaging Using PowerVison (Principles and Features) |
|
|
70 | (1) |
|
|
|
70 | (1) |
|
|
|
71 | (1) |
|
|
|
71 | (1) |
|
Techniques and Crucial Points for the Use of PowerVision |
|
|
71 | (2) |
|
Visualization of Perfusion Image |
|
|
72 | (1) |
|
Visualization of Vessel Image |
|
|
73 | (1) |
|
Application Method and Main Point for Toshiba PowerVision 8000 |
|
|
73 | (1) |
|
|
|
73 | (1) |
|
|
|
73 | (1) |
|
|
|
73 | (1) |
|
|
|
73 | (1) |
|
Clinical Cases of Harmonic Imaging by Using Toshiba PowerVision 8000 |
|
|
73 | (32) |
|
Remarkable difference in vascularity due to different degrees of differentiation |
|
|
75 | (1) |
|
Harmonic power Doppler images of a 2.5-cm HCC in S6 |
|
|
76 | (1) |
|
Visualization of HCC by using digital subtraction B-mode |
|
|
77 | (1) |
|
Harmonic B-mode image of a small HCC |
|
|
78 | (1) |
|
A dynamic study of harmonic power Doppler in a small HCC (gradual increment of intermittent transmission interval) |
|
|
79 | (3) |
|
A dynamic study of harmonic power Doppler (fixed intermittent transmission interval) |
|
|
82 | (2) |
|
A dynamic study of harmonic power Doppler (gradual increment of intermittent transmission interval) |
|
|
84 | (2) |
|
A dynamic study of harmonic power Doppler (gradual increment of intermittent transmission interval) |
|
|
86 | (1) |
|
Harmonic power Doppler image of a recurrent nodule after treatment with transcatheter arterial embolization (TAE) |
|
|
87 | (1) |
|
A case of HCC with central necrosis |
|
|
88 | (2) |
|
Visualization of blood flow in the local recurrent area after treatment |
|
|
90 | (1) |
|
Evaluation of blood flow in the nodule after treatment |
|
|
91 | (2) |
|
Evaluation of treatment response after percutaneous ethanol injection (PEI) therapy |
|
|
93 | (2) |
|
A case of HCC with complete response after RFA |
|
|
95 | (2) |
|
A case of HCC with complete response after RFA |
|
|
97 | (1) |
|
A case of HCC with complete response after Lipiodol TAE (LpTAE) and RFA |
|
|
98 | (1) |
|
A case of HCC with complete response after LpTAE and RFA |
|
|
99 | (1) |
|
A case of HCC with complete response after LpTAE and RFA |
|
|
100 | (1) |
|
A case of HCC with complete response after RFA |
|
|
101 | (1) |
|
Harmonic power Doppler image of hemangioma |
|
|
102 | (1) |
|
Harmonic image of metastatic liver cancer |
|
|
103 | (1) |
|
Harmonic image of focal nodular hyperplasia |
|
|
104 | (1) |
|
Application Method and Main Point for Toshiba Aplio |
|
|
105 | (2) |
|
|
|
105 | (1) |
|
|
|
105 | (1) |
|
|
|
105 | (1) |
|
|
|
105 | (1) |
|
Summary of Advanced Dynamic Flow and Pulse Subtraction Imaging |
|
|
106 | (1) |
|
Clinical Cases of Harmonic Imaging by Using Toshiba Aplio |
|
|
107 | (9) |
|
|
|
107 | (2) |
|
ADF and PS images of metastatic liver cancer |
|
|
109 | (2) |
|
A case of typical hepatic hemangioma |
|
|
111 | (2) |
|
A case of adenomatous hyperplasia |
|
|
113 | (2) |
|
A case of recurrent HCC after RFA treatment |
|
|
115 | (1) |
|
|
|
116 | (3) |
|
|
|
119 | (2) |
|
Pulse Inversion Harmonic Imaging (ATL HDI 5000) |
|
|
121 | (7) |
|
|
|
121 | (1) |
|
|
|
122 | (3) |
|
|
|
123 | (1) |
|
|
|
123 | (1) |
|
Quantification Application |
|
|
124 | (1) |
|
Application Method and Main Point for ATL HDI 5000 |
|
|
125 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
Clinical Cases Using Pulse Inversion Harmonics on the ATL HDI 5000 |
|
|
125 | (3) |
|
|
|
126 | (1) |
|
|
|
127 | (1) |
|
Agent Detection Imaging (ADI) (Acuson Sequoia 512) |
|
|
128 | (17) |
|
|
|
128 | (3) |
|
|
|
128 | (2) |
|
Equalization of Sound Pressure |
|
|
130 | (1) |
|
|
|
131 | (1) |
|
Application Method and Main Point for Acuson Sequoia 512 |
|
|
131 | (1) |
|
|
|
131 | (1) |
|
|
|
132 | (1) |
|
|
|
132 | (1) |
|
|
|
132 | (1) |
|
Clinical Cases of ADI Using Acuson Sequoia 512 |
|
|
132 | (13) |
|
Hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) after radiofrequency ablation (RFA) treatment |
|
|
132 | (2) |
|
A case of HCC with complete response after RFA |
|
|
134 | (1) |
|
|
|
135 | (1) |
|
|
|
136 | (2) |
|
|
|
138 | (2) |
|
|
|
140 | (2) |
|
A case of recurrent cholangiocellular carcinoma after RFA |
|
|
142 | (1) |
|
Recurrent HCC after transcatheter arterial embolization (TAE) |
|
|
143 | (2) |
|
Coded Harmonic Angio (GE LOGIQ 700 EXPERT Series) |
|
|
145 | (35) |
|
Principles of Coded Harmonic Angio |
|
|
145 | (1) |
|
Characteristics of the GE LOGIQ 700 EXPERT, LOGIQ 7 and LOGIQ 9 Series |
|
|
146 | (2) |
|
|
|
147 | (1) |
|
|
|
147 | (1) |
|
Application Method and Main Point for GE LOGIQ 700 EXPERT (CHA) |
|
|
148 | (1) |
|
|
|
148 | (1) |
|
|
|
148 | (1) |
|
|
|
148 | (1) |
|
|
|
148 | (1) |
|
Clinical Cases of Harmonic Images Using CHA |
|
|
148 | (31) |
|
Typical image of hepatocellular carcinoma (HCC) |
|
|
149 | (1) |
|
Depiction of tumor vascularity in a small HCC |
|
|
150 | (1) |
|
Evaluation of treatment response after radiofrequency ablation (RFA) for HCC: CHA images of case 2 after one RFA treatment |
|
|
151 | (1) |
|
Evaluation of the safety margin after retreatment: CHA images after additional RFA was given to the same case |
|
|
152 | (1) |
|
|
|
153 | (1) |
|
Untreated HCC in the left liver lobe |
|
|
154 | (1) |
|
CHA images of a small HCC |
|
|
155 | (2) |
|
Evaluating treatment response after Lipiodol transcatheter arterial embolization (LpTAE) |
|
|
157 | (1) |
|
Evaluating treatment response after additional RFA: Complete response |
|
|
158 | (1) |
|
Comparison of CHA and intraarterial contrast-enhanced US in a typical HCC |
|
|
159 | (2) |
|
Evaluating treatment response after LpTAE and RFA treatment: Complete response case |
|
|
161 | (1) |
|
CHA image of a typical HCC |
|
|
162 | (1) |
|
Evaluation of blood flow after Lipiodol transcatheter arterial infusion chemotherapy (LpTAI): Incomplete response |
|
|
163 | (1) |
|
Evaluation of blood flow after additional RFA treatment |
|
|
164 | (1) |
|
CHA image of a small, deeply located HCC |
|
|
165 | (1) |
|
Evaluating treatment response after RFA |
|
|
166 | (1) |
|
A CHA image of a small HCC |
|
|
167 | (1) |
|
Difference in detectability in relation to the distance from body surface |
|
|
168 | (1) |
|
|
|
169 | (2) |
|
Depiction of the vascularity of HCC |
|
|
171 | (1) |
|
Depiction of typical HCC vascularity |
|
|
172 | (1) |
|
Weeping-willow-like vascularity in HCC |
|
|
173 | (2) |
|
CHA image after RFA treatment |
|
|
175 | (1) |
|
|
|
176 | (1) |
|
Vascularity of a typical HCC |
|
|
177 | (1) |
|
|
|
178 | (1) |
|
|
|
179 | (1) |
|
Differential Diagnosis of Various Hepatic Tumors by Harmonic Imaging |
|
|
180 | (36) |
|
Key Points in Differentiation |
|
|
180 | (1) |
|
|
|
180 | (36) |
|
Vascularity of a giant HCC |
|
|
181 | (1) |
|
|
|
182 | (1) |
|
|
|
183 | (1) |
|
|
|
184 | (1) |
|
Harmonic imaging of a dysplastic nodule (adenomatous hyperplasia) |
|
|
185 | (1) |
|
Harmonic imaging of a dysplastic nodule (adenomatous hyperplasia) |
|
|
186 | (2) |
|
Harmonic image of a nodule with portal blood inflow (borderline lesion) |
|
|
188 | (1) |
|
Harmonic imaging of a nodule-in-nodule type HCC |
|
|
189 | (1) |
|
Typical harmonic image of a cavernous hemangioma |
|
|
190 | (1) |
|
Typical cavernous hemangioma |
|
|
191 | (1) |
|
Spotty pooling of typical hemangioma |
|
|
192 | (1) |
|
Harmonic image of cavernous hemangioma (cotton-wool appearance) |
|
|
193 | (2) |
|
Harmonic image of capillary hemangioma |
|
|
195 | (2) |
|
Harmonic image of a typical hemangioma |
|
|
197 | (2) |
|
Hemangioma showing atypical hemodynamics |
|
|
199 | (1) |
|
Depiction of a small metastatic lesion |
|
|
200 | (1) |
|
Breast cancer with liver metastasis |
|
|
201 | (1) |
|
|
|
202 | (2) |
|
Involvement of preexisting blood vessels in metastatic liver cancer |
|
|
204 | (1) |
|
A CHA image of typical metastatic liver cancer |
|
|
205 | (1) |
|
A case of metastatic liver cancer with hypervascularity |
|
|
206 | (2) |
|
CHA image of cholangiocellular carcinoma |
|
|
208 | (2) |
|
Harmonic image of a small cholangiocellular carcinoma |
|
|
210 | (1) |
|
Harmonic image of focal nodular hyperplasia |
|
|
211 | (1) |
|
Typical harmonic image of focal nodular hyperplasia |
|
|
212 | (2) |
|
Angiomyolipoma with depiction of drainage blood flow |
|
|
214 | (2) |
|
The Roles of Contrast-Enhanced Harmonic Imaging in Treating Hepatocellular Carcinoma |
|
|
216 | (27) |
|
|
|
216 | (1) |
|
Assessment of Treatment Response |
|
|
216 | (1) |
|
Recognition of Local Recurrence |
|
|
217 | (1) |
|
Localization of Residual Tumor |
|
|
218 | (1) |
|
Real-time Needle Insertion Guidance by US for Further Treatment |
|
|
218 | (1) |
|
|
|
218 | (25) |
|
Judgment of treatment response after RFA |
|
|
219 | (1) |
|
Typical CHA image of HCC before treatment |
|
|
220 | (2) |
|
Harmonic imaging of the same case after LpTAE treatment |
|
|
222 | (1) |
|
CHA image after LpTAE and RFA treatment: Incomplete response |
|
|
223 | (1) |
|
Harmonic imaging of local recurrence after treatment |
|
|
224 | (1) |
|
Harmonic imaging of a complete response to additional RFA treatment |
|
|
225 | (1) |
|
Complete response after LpTAE and RFA treatment |
|
|
226 | (1) |
|
Complete response after one-time RFA treatment |
|
|
227 | (1) |
|
Judgment of treatment response after RFA |
|
|
228 | (2) |
|
Assessment of treatment response after TAE on HCC |
|
|
230 | (2) |
|
Assessment of the treatment response of transcatheter arterial infusion (TAI) on HCC |
|
|
232 | (1) |
|
Assessment of the treatment response of RFA |
|
|
233 | (1) |
|
Harmonic imaging of local recurrence |
|
|
234 | (1) |
|
Recurrence in a peripheral region after TAE treatment |
|
|
235 | (1) |
|
Depiction of residual tumor after LpTAE treatment: A different result from CT |
|
|
236 | (1) |
|
Depiction of residual tumor after TAE treatment |
|
|
237 | (1) |
|
Evaluation after additional RFA |
|
|
238 | (1) |
|
Tumor residue after TAE treatment |
|
|
239 | (1) |
|
Harmonic imaging of local recurrence after PMCT treatment |
|
|
240 | (1) |
|
Local treatment under the guidance of harmonic imaging |
|
|
241 | (1) |
|
Additional RFA treatment under the guidance of harmonic imaging: Complete response |
|
|
242 | (1) |
|
Postvascular Phase Sweep Scan Using Liver-Specific Imaging |
|
|
243 | (3) |
|
Sweep scan of metastatic liver cancer |
|
|
243 | (3) |
|
The Role of Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment of Hepatic Tumors (Summary) |
|
|
246 | (2) |
|
Application of Contrast-Enhanced Harmonic Imaging in Biliary and Pancreatic Tumors |
|
|
248 | (3) |
|
The Usefulness of Intraarterial Contrast-Enhanced US |
|
|
248 | (1) |
|
Application of Harmonic Imaging in Biliary and Pancreatic Tumors |
|
|
248 | (3) |
|
A case of a pancreatic islet cell tumor |
|
|
249 | (2) |
|
Update and Direction of Ultrasonic Contrast Agents |
|
|
251 | (3) |
| Subject Index |
|
254 | |